These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20180535)

  • 21. [Effect of humectants on pharmaceutical availability and rheological properties of loratadine-containing hydrogels].
    Capková Z; Vitková Z; Vysokaiová V
    Ceska Slov Farm; 2005 Jul; 54(4):187-91. PubMed ID: 16124201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of loratadine and further characterization of its in vitro metabolites.
    Ghosal A; Gupta S; Ramanathan R; Yuan Y; Lu X; Su AD; Alvarez N; Zbaida S; Chowdhury SK; Alton KB
    Drug Metab Lett; 2009 Aug; 3(3):162-70. PubMed ID: 19702548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
    Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous determination of loratadine and desloratadine in pharmaceutical preparations using liquid chromatography with a microemulsion as eluent.
    El-Sherbiny DT; El-Enany N; Belal FF; Hansen SH
    J Pharm Biomed Anal; 2007 Mar; 43(4):1236-42. PubMed ID: 17126519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loratadine and analogues: discovery and preliminary structure-activity relationship of inhibitors of the amino acid transporter B(0)AT2.
    Cuboni S; Devigny C; Hoogeland B; Strasser A; Pomplun S; Hauger B; Höfner G; Wanner KT; Eder M; Buschauer A; Holsboer F; Hausch F
    J Med Chem; 2014 Nov; 57(22):9473-9. PubMed ID: 25318072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization.
    Brock EJ; Ji K; Reiners JJ; Mattingly RR
    Mini Rev Med Chem; 2016; 16(5):358-69. PubMed ID: 26423696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PREPARATION AND CHARACTERIZATION OF ORALLY DISINTEGRATING LORATADINE TABLETS MANUFACTURED WITH CO-PROCESSED MIXTURES.
    Amelian A; Szekalska M; Wilczewska AZ; Basa A; Winnicka K
    Acta Pol Pharm; 2016; 73(2):453-60. PubMed ID: 27180438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors.
    Haney SL; Wills VS; Wiemer DF; Holstein SA
    Molecules; 2017 May; 22(6):. PubMed ID: 28555000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of the novel farnesyltransferase inhibitor RPR130401 and the geranylgeranyltransferase-1 inhibitor GGTI-298 disrupts MAP kinase activation and G(1)-S transition in Ki-Ras-overexpressing transformed adrenocortical cells.
    Mazet JL; Padieu M; Osman H; Maume G; Mailliet P; Dereu N; Hamilton AD; Lavelle F; Sebti SM; Maume BF
    FEBS Lett; 1999 Oct; 460(2):235-40. PubMed ID: 10544242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similar substrate specificity of cynomolgus monkey cytochrome P450 2C19 to reported human P450 2C counterpart enzymes by evaluation of 89 drug clearances.
    Hosaka S; Murayama N; Satsukawa M; Uehara S; Shimizu M; Iwasaki K; Iwano S; Uno Y; Yamazaki H
    Biopharm Drug Dispos; 2015 Dec; 36(9):636-43. PubMed ID: 26348733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical equivalent studies of some commercially available brands of Loratadine hydrochloride tablets.
    Adetunji OA; Adigun NF; Odeniyi MA
    Afr J Med Med Sci; 2015 Sep; 44(3):269-76. PubMed ID: 27280240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereoselective synthesis of desloratadine derivatives as antagonist of histamine.
    Liu GZ; Xu HW; Chen GW; Wang P; Wang YN; Liu HM; Yu DQ
    Bioorg Med Chem; 2010 Feb; 18(4):1626-32. PubMed ID: 20110173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors.
    Abuhaie CM; Ghinet A; Farce A; Dubois J; Rigo B; Bîcu E
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5887-92. PubMed ID: 24054122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein farnesyltransferase inhibitors.
    Ayral-Kaloustian S; Salaski EJ
    Curr Med Chem; 2002 May; 9(10):1003-32. PubMed ID: 12733981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring isoxazoles and pyrrolidinones decorated with the 4,6-dimethoxy-1,3,5-triazine unit as human farnesyltransferase inhibitors.
    Lucescu L; Ghinet A; Shova S; Magnez R; Thuru X; Farce A; Rigo B; Belei D; Dubois J; Bîcu E
    Arch Pharm (Weinheim); 2019 May; 352(5):e1800227. PubMed ID: 30947375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem.
    Sousa SF; Fernandes PA; Ramos MJ
    Curr Med Chem; 2008; 15(15):1478-92. PubMed ID: 18537624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histamine H1 type receptor antagonist loratadine ameliorates oxidized LDL induced endothelial dysfunction.
    Zhou Y; Gao C; Wang H; Liu L; Huang Z; Fa X
    Biomed Pharmacother; 2018 Oct; 106():1448-1453. PubMed ID: 30119218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice.
    Sugita M; Sugita H; Kaneki M
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1390-5. PubMed ID: 17363690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview on natural farnesyltransferase inhibitors for efficient cancer therapy.
    Dai X; Sun Y; Zhang T; Ming Y; Hongwei G
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1027-1044. PubMed ID: 32308053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Driven to death: Inhibition of farnesylation increases Ras activity and promotes growth arrest and cell death [corrected].
    Geryk-Hall M; Yang Y; Hughes DP
    Mol Cancer Ther; 2010 May; 9(5):1111-9. PubMed ID: 20406948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.